Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px download
Document › Details

Immunicum AB. (8/22/17). "Press Release: Immunicum AB (publ) Announces Upcoming Presentations at Conferences in August and September".

Organisations Organisation Immunicum AB (publ; First North Premier: IMMU.ST)
  Organisation 2 Pareto Securities AS
  Group Pareto Group (Group)
Products Product Swedish-American Life Science Summit 2017 Stockholm
  Product 2 Pareto Securities’ Annual Healthcare Conference 2017 Stockholm
Persons Person de Sousa, Carlos (Immunicum 201610– CEO before Zealand Pharma + Nycomed/Takeda + Pfizer + Novartis + BBB Therapeutics)
  Person 2 Schweitzer, Gretchen (MacDougall 201307 European Office)
     


Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel, immune-priming cancer treatment against a variety of solid tumors, today announced that Immunicum leadership will present the Company at several upcoming investor and partnering conferences in August and September.

Swedish-American Life Science Summit 2017
Date: August 23 - 25, 2017
Presentation Time: August 25, 12:00 pm Central European Time
Venue: Nasdaq Stockholm, Tullvaktsvägen 15, Stockholm, Sweden

Pareto Securities' 8th Annual Healthcare Conference
Date: September 7, 2017
Presentation Time: 12:15 pm Central European Time
Venue: Conference 7A Strandvägen 7A Stockholm, Sweden

24th Annual NewsMakers in the Biotech Industry
Date: September 8, 2017
Presentation Time: 8:30 - 8:55 am Eastern Standard Time
Venue: Millennium Broadway Hotel & Conference Center, New York, NY

Rodman & Renshaw 19th Annual Global Investment Conference
Date: September 10 - 12, 2017
Presentation Time: September 11, 5:30 - 5:55 pm Eastern Standard Time
Venue: Lotte New York Palace Hotel, New York, NY

Nordic Life Science Days 2017
Date: September 12 - 14, 2017
Presentation Time: September 13, 10:40 am Central European Time
Venue: Malmömässan, Mässgatan 6, Hyllie, Malmö, Sweden

RedEye Cancer Immunotherapy "Special Event"
Date: September 21, 2017
Presentation Time: TBD - time will be posted on Immunicum website
Venue: Redeye, Mäster Samuelsgatan 42, 10 tr, Stockholm, Sweden

BioPharm America
Date: September 26 - 27, 2017
Presentation Time: TBD - time will be posted on Immunicum website
Venue: Sheraton Boston Hotel, Boston, MA

17th Annual Sachs Biotech in Europe Forum
Date: September 26 - 27, 2017
Presentation Time: September 27, 12:00 pm Central European Time
Venue: Congress Center Basel, Switzerland


For more information, please contact:

Carlos de Sousa, CEO, Immunicum
Telephone: +46 (0) 31 41 50 52
E-mail: info@immunicum.com

Investor Relations Sweden
Helena Stångberg
Hallvarsson & Halvarsson
Telephone: + 46 709 71 12 53
E-mail: helena.stangberg@halvarsson.se

Investor and Media Relations EU/US
MacDougall Biomedical Communications
Gretchen Schweitzer or Stephanie May
Telephone: +49 89 2424 3494 or +49 175 5711562
E-mail: gschweitzer@macbiocom.com or smay@macbiocom.com

The Company's Certified Adviser is Redeye AB
Telephone: +46 (0) 8 545 013 31
www.redeye.se


About Immunicum AB (publ)

Immunicum is establishing a unique immuno-oncology approach through the development of allogeneic, off-the-shelf cell-based therapies. Our goal is to improve survival outcomes and quality of life by priming the patient's own immune system to fight cancer. The company's lead product ilixadencel, consisting of pro-inflammatory allogeneic dendritic cells, has the potential to become a backbone component of modern cancer combination treatments in a variety of solid tumor indications. Founded and based in Sweden, Immunicum is publicly traded on the Nasdaq First North Premier. www.immunicum.com

   
Record changed: 2017-08-29

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Immunicum AB (publ; First North Premier: IMMU.ST)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px




» top

Advertisements

Picture Berlin Partner HealthCapital BIO-Europe 2017 Germany November 120x240px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px 3 Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Save USD100 120x180px Picture Berlin Partner HealthCapital BIO-Europe 2017 Germany November 120x240px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px 40 Picture EBD Group BioPharm America 2017 BPA Boston MA Save USD100 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px